Literature DB >> 24797065

Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy.

Marisa Accogli1, Tommaso Giani2, Monica Monaco1, Maria Giufrè1, Aurora García-Fernández1, Viola Conte2, Fortunato D'Ancona3, Annalisa Pantosti1, Gian Maria Rossolini4, Marina Cerquetti5.   

Abstract

Entities:  

Keywords:  carbapenems; multidrug resistance; multilocus sequence typing

Mesh:

Substances:

Year:  2014        PMID: 24797065     DOI: 10.1093/jac/dku132

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  17 in total

1.  Coexistence of CTX-M-2, CTX-M-55, CMY-2, FosA3, and QnrB19 in Extraintestinal Pathogenic Escherichia coli from Poultry in Brazil.

Authors:  Marcos P V Cunha; Nilton Lincopan; Louise Cerdeira; Fernanda Esposito; Milena Dropa; Leticia S Franco; Andrea M Moreno; Terezinha Knöbl
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

2.  TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam.

Authors:  Alessandra Piccirilli; Mariagrazia Perilli; Gianfranco Amicosante; Viola Conte; Carlo Tascini; Gian Maria Rossolini; Tommaso Giani
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

Review 3.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.

Authors:  Sarah M Drawz; Stephen Porter; Michael A Kuskowski; Brian Johnston; Connie Clabots; Susan Kline; Patricia Ferrieri; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

5.  Escherichia coli Sequence Type 457 Is an Emerging Extended-Spectrum-β-Lactam-Resistant Lineage with Reservoirs in Wildlife and Food-Producing Animals.

Authors:  Steven P Djordjevic; Monika Dolejska; Kristina Nesporova; Ethan R Wyrsch; Adam Valcek; Ibrahim Bitar; Khin Chaw; Patrick Harris; Jaroslav Hrabak; Ivan Literak
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

6.  Threading the Needle: Small-Molecule Targeting of a Xenobiotic Receptor to Ablate Escherichia coli Polysaccharide Capsule Expression Without Altering Antibiotic Resistance.

Authors:  Mehreen Arshad; Carlos C Goller; Danielle Pilla; Frank J Schoenen; Patrick C Seed
Journal:  J Infect Dis       Date:  2015-12-15       Impact factor: 5.226

7.  Diversity of Carbapenemase-Producing Escherichia coli Isolates in France in 2012-2013.

Authors:  Lauraine Gauthier; Laurent Dortet; Garance Cotellon; Elodie Creton; Gaëlle Cuzon; Valérie Ponties; Rémy A Bonnin; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

Review 8.  Molecular Characterization of the Multidrug Resistant Escherichia coli ST131 Clone.

Authors:  Mark A Schembri; Nouri L Ben Zakour; Minh-Duy Phan; Brian M Forde; Mitchell Stanton-Cook; Scott A Beatson
Journal:  Pathogens       Date:  2015-06-26

9.  Complete Genome Sequence of a Carbapenem-Resistant Extraintestinal Pathogenic Escherichia coli Strain Belonging to the Sequence Type 131 H30R Subclade.

Authors:  Timothy J Johnson; Melissa Hargreaves; Kristin Shaw; Paula Snippes; Ruth Lynfield; Maliha Aziz; Lance B Price
Journal:  Genome Announc       Date:  2015-04-09

Review 10.  Review on colonization of residents and staff in Italian long-term care facilities by multidrug-resistant bacteria compared with other European countries.

Authors:  Richard Aschbacher; Elisabetta Pagani; Massimo Confalonieri; Claudio Farina; Paolo Fazii; Francesco Luzzaro; Pier Giorgio Montanera; Aurora Piazza; Laura Pagani
Journal:  Antimicrob Resist Infect Control       Date:  2016-10-11       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.